Search research articles
Contact Us
Filters
Showing results (1-10 of 169) with videos related to
Page
of 17
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment
|
August 29, 2002
Meeting report: the next interleukin?
Georg F Weber
Medical Hypotheses
|
March 15, 2013
Gene therapy--why can it fail?
Georg F Weber
Cancer Letters
|
June 5, 2008
Molecular mechanisms of metastasis
Georg F Weber
BMC Pulmonary Medicine
|
April 17, 2015
Immune targeting of the pleural space by intercostal approach
Georg F Weber
International Journal of Molecular Sciences
|
August 30, 2018
The Phylogeny of Osteopontin-Analysis of the Protein Sequence
Georg F Weber
Oncoscience
|
May 20, 2020
Cancer research - can the entity be bigger than the sum of its parts?
Georg F Weber
Cancer Genomics & Proteomics
|
November 17, 2011
The cancer biomarker osteopontin: combination with other markers
Georg F Weber
Autoimmunity
|
April 30, 2004
The absence of CD44 ameliorates Fas(lpr/lpr) disease
Georg F Weber
Toxicology
|
October 28, 2009
Toward a molecular classification of cancer
Georg F Weber
Medicine International
|
April 3, 2026
Osteopontin in pancreatic cancer: A systematic review
Georg F Weber
Page
of 17
Search research articles
Search
Showing results (1-10 of 169) with videos related to
Sort By:
Page
of 17
Science'S STKE : Signal Transduction Knowledge Environment
|
August 29, 2002
Meeting report: the next interleukin?
Georg F Weber
Medical Hypotheses
|
March 15, 2013
Gene therapy--why can it fail?
Georg F Weber
Cancer Letters
|
June 5, 2008
Molecular mechanisms of metastasis
Georg F Weber
BMC Pulmonary Medicine
|
April 17, 2015
Immune targeting of the pleural space by intercostal approach
Georg F Weber
International Journal of Molecular Sciences
|
August 30, 2018
The Phylogeny of Osteopontin-Analysis of the Protein Sequence
Georg F Weber
Oncoscience
|
May 20, 2020
Cancer research - can the entity be bigger than the sum of its parts?
Georg F Weber
Cancer Genomics & Proteomics
|
November 17, 2011
The cancer biomarker osteopontin: combination with other markers
Georg F Weber
Autoimmunity
|
April 30, 2004
The absence of CD44 ameliorates Fas(lpr/lpr) disease
Georg F Weber
Toxicology
|
October 28, 2009
Toward a molecular classification of cancer
Georg F Weber
Medicine International
|
April 3, 2026
Osteopontin in pancreatic cancer: A systematic review
Georg F Weber
Page
of 17